Suppr超能文献

肾素 - 血管紧张素拮抗剂与血压调节

Renin--angiotensin antagonists and the regulation of blood pressure.

作者信息

Samuels A I, Miller E D, Fray J C, Haber E, Barger A C

出版信息

Fed Proc. 1976 Nov;35(13):2512-20.

PMID:185095
Abstract

The role of the renin--angiotensin system in the regulation of blood pressure in dogs and in human subjects was assessed by the use of the nonapeptide converting enzyme inhibitor (CEI), permitting the following conclusions: 1) In the normal, sodium replete dog, the renin--angiotensin system plays little role in the regulation of blood pressure. 2) As sodium depletion progresses, the renin--angiotensin system becomes increasingly important in the maintenance of blood pressure. In the markedly hypovolemic animal, blocking the conversion of angiotensin I to angiotensin II leads to prolonged hypotension of shock-like levels. 3) The renin--angiotensin system is responsible for the initiation of renovascular hypertension. Blood pressure does not rise during chronic renal artery constriction when the generation of angiotensin II is prevented by the CEI. Although angiotensin II is essential for the initiation of the elevated blood pressure, the renin--angiotensin system plays a decreasing role in the maintenance of the chronic hypertension as sodium and water are retained, and plasma volume increases. 4) In congestive failure induced in the conscious dog by circulatory impairment, the renin--angiotensin--aldosterone system plays an essential role in the compensatory response. During chronic administration of the CEI, the animal cannot compensate even for a relatively mild degree of constriction, and remains hypotensive. In the dog with congestive failure, as in the dog with renovascular hypertension, plasma renin activity (PRA) and plasma aldosterone are elevated early in the syndrome; during this phase, injection of the nonapeptide produces a marked drop in blood pressure. With the retention of sodium and water, and expansion of plasma and extravascular fluid volumes, PRA and plasma aldosterone return to control levels in the new steady state. The inhibitor no longer produces a drop in blood pressure. Thus, the sequential changes in the renin--angiotensin--aldosterone system are remarkably similar in renovascular hypertension and congestive failure. 5) In the normal, salt replete human subject the renin--angiotensin system plays little role in the regulation of blood pressure either in the recumbent or upright posture. However, with relatively mild sodium depletion, the CEI transiently lowers blood pressure even in the recumbent subject. In the absence of angiotensin II such sodium-depleted subjects are unable to compensate when tilted upright, and faint within minutes.

摘要

通过使用九肽转化酶抑制剂(CEI)评估了肾素 - 血管紧张素系统在犬类和人类受试者血压调节中的作用,得出以下结论:1)在正常、钠充足的犬类中,肾素 - 血管紧张素系统在血压调节中作用很小。2)随着钠缺失的进展,肾素 - 血管紧张素系统在维持血压方面变得越来越重要。在明显低血容量的动物中,阻断血管紧张素I向血管紧张素II的转化会导致类似休克水平的长时间低血压。3)肾素 - 血管紧张素系统是肾血管性高血压发病的原因。当CEI阻止血管紧张素II生成时,慢性肾动脉狭窄期间血压不会升高。虽然血管紧张素II对于血压升高的起始至关重要,但随着钠和水的潴留以及血浆容量增加,肾素 - 血管紧张素系统在维持慢性高血压中的作用逐渐减弱。4)在有意识的犬类中,由循环障碍引起的充血性心力衰竭时,肾素 - 血管紧张素 - 醛固酮系统在代偿反应中起重要作用。在长期给予CEI期间,动物即使对于相对轻度的心衰也无法代偿,并且持续低血压。在患有充血性心力衰竭的犬类中,与患有肾血管性高血压的犬类一样,血浆肾素活性(PRA)和血浆醛固酮在综合征早期升高;在此阶段,注射九肽会导致血压显著下降。随着钠和水的潴留以及血浆和血管外液体积的增加,PRA和血浆醛固酮在新的稳态下恢复到对照水平。抑制剂不再导致血压下降。因此,肾血管性高血压和充血性心力衰竭中肾素 - 血管紧张素 - 醛固酮系统的相继变化非常相似。5)在正常、钠充足的人类受试者中,无论卧位还是立位,肾素 - 血管紧张素系统在血压调节中作用很小。然而,在相对轻度的钠缺失情况下,即使是卧位受试者,CEI也会使血压短暂降低。在没有血管紧张素II的情况下,这些钠缺失的受试者在直立倾斜时无法代偿,几分钟内就会昏厥。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验